# Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma

> **NCT00721890** · PHASE2 · COMPLETED · sponsor: **CHU de Quebec-Universite Laval** · enrollment: 16 (actual)

## Conditions studied

- Ovarian Carcinoma

## Interventions

- **DIETARY_SUPPLEMENT:** Double-Brewed Green Tea

## Key facts

- **NCT ID:** NCT00721890
- **Lead sponsor:** CHU de Quebec-Universite Laval
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2013-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00721890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00721890, "Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00721890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*